Equities
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Brenntag SE, former Brenntag AG, is a Germany-based company active in the field of full-line chemical distribution. It provides business-to-business distribution solutions for industrial and specialty chemicals. The Company purchases and stores large-scale quantities of industrial and specialty chemicals and repackages them into smaller quantities. In addition, the Company also offers additional services, including delivery, product mixing, blending, repackaging, micronization and fine milling, inventory management and drum return handling, as well as technical and laboratory services for specialty chemicals. The Company offers its products to a range of market industries, such as adhesives, paints, oil & gas, food, water treatment, personal care and pharmaceuticals. The Company operates through a network with more than 550 locations in Europe, North and Latin America, and in the Asia Pacific region.

  • Revenue in EUR (TTM)19.43bn
  • Net income in EUR886.80m
  • Incorporated2017
  • Employees17.54k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
BNRX.N:GER since
announced
Transaction
value
Aik Moh Paints & Chemicals Pte LtdAnnounced22 Mar 202322 Mar 2023Announced1.33%--
Undisclosed Water Treatment FacilityDeal completed22 Feb 202322 Feb 2023Deal completed-5.86%--
Univar Solutions IncDeal withdrawn25 Nov 202225 Nov 2022Deal withdrawn0.41%--
Ravenswood Pty Ltd-Life Sciences & Coating BusinessAnnounced02 Nov 202202 Nov 2022Announced10.30%--
Prime Surfactants LtdDeal completed23 Aug 202223 Aug 2022Deal completed1.54%--
Data delayed at least 15 minutes, as of Mar 30 2023 16:29 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Azelis Group NV4.11bn213.19m5.37bn3.83k25.212.2517.701.310.91170.911717.5710.200.91745.788.371,074,275.004.89--6.06--23.00--5.33--0.83747.520.3705--45.34--214.65------
Turkiye Sise ve Cam Fabrikalari A.S.4.59bn932.03m6.34bn24.93k6.731.695.221.386.396.3931.5325.410.74434.516.573,824,534.0015.7212.9023.7218.9335.3534.3221.1220.921.53--0.330315.56197.4353.15113.9973.6454.0449.01
Oci NV8.96bn1.14bn6.40bn4.06k5.632.982.300.71465.405.4042.3710.190.99216.6411.622,206,925.0024.787.4640.7311.0134.4726.4824.9812.761.2618.440.4207155.0853.7233.96116.90--21.75--
Arkema SA11.55bn949.00m6.69bn20.41k7.210.91334.100.57912.3612.36151.5197.580.89496.698.27565,843.607.486.969.068.4022.3421.828.368.331.4021.520.307527.3121.346.77-26.6011.949.728.13
Umicore SA-100.00bn-100.00bn7.41bn11.35k--2.05----------14.64----------5.17--8.58--6.35--1.940.763--0.396630.445.7416.31-7.9321.555.462.71
Imcd NV4.60bn313.08m8.36bn4.32k26.674.9919.991.825.505.5080.8329.391.336.256.961,064,421.009.056.6512.439.2622.0720.876.805.341.0410.690.427444.1833.9519.2651.0532.2910.6630.76
Evonik Industries AG18.49bn540.00m8.88bn34.03k16.430.80944.190.48041.161.1639.6523.550.83865.319.60543,301.302.513.113.053.7322.8826.783.004.591.05--0.291483.6423.625.15-27.94-5.44-3.620.3454
Chr Hansen Holding A/S1.26bn228.34m9.09bn3.69k39.735.2226.907.2212.9312.9371.3298.440.39363.247.752,539,439.007.148.948.0511.0955.2857.5718.1421.000.960110.440.376962.4613.052.7713.290.0985.96-10.07
Akron PAO2.04bn694.40m9.11bn11.21k12.067.8710.784.471,562.541,562.544,595.302,395.290.73542.9921.09--25.348.4035.9812.1759.9047.3434.4615.831.10--0.448981.994.385.43-86.33-26.953.50-19.73
Yara International ASA22.00bn2.56bn10.22bn17.50k4.001.292.960.4644113.26113.26974.78350.211.364.1510.7614,188,590.0015.785.4521.957.1127.3927.0911.645.890.9809466.000.329168.8743.8416.05518.4942.24-7.1452.98
Brenntag SE19.43bn886.80m10.52bn17.54k11.862.218.290.54125.745.74125.7630.761.808.907.821,107,714.008.376.3012.308.8822.2322.404.653.901.2820.940.39235.9535.0910.5997.8119.7012.0312.70
Novozymes A/S2.36bn493.49m10.63bn6.44k26.416.9615.314.5113.1913.1962.9650.030.66552.355.322,726,468.0013.9814.7718.7419.5354.5656.2621.0021.310.78124.890.324947.3717.403.8516.853.3411.305.92
PhosAgro PAO6.79bn2.20bn11.45bn25.00k5.214.874.471.691,425.961,425.964,397.891,525.581.326.6812.10--42.9024.1555.4030.9052.7846.5632.4323.350.7992--0.494987.7935.4425.7242.3848.7812.2080.76
Akzo Nobel NV10.85bn362.00m11.69bn35.20k33.372.7015.461.082.062.0061.8525.420.7583.964.53308,125.002.713.954.415.6036.1741.073.586.180.765911.430.563767.8313.132.45-56.01-3.783.15-6.78
Data as of Mar 30 2023. Currency figures normalised to Brenntag SE's reporting currency: Euro EUR
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.